ADMA Biologics Appoints Plasma Industry Leader Lawrence Guiheen to Board of Directors
08:30 EDT 24 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused
on the development and commercialization of human plasma and
plasma-derived therapeutics, today announced it has appointed Lawrence
Guiheen to its Board of ...
Other Sources for this Article
ADMA Biologics, Inc.
Adam S. Grossman, 201-478-5552
President
& CEO
or
Brian Lenz, CPA, 201-478-5552
Vice President
& Chief Financial Officer
info@admabio.com
More From BioPortfolio on "ADMA Biologics Appoints Plasma Industry Leader Lawrence Guiheen to Board of Directors"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
